Immune Deficiency
40
8
8
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
4 terminated out of 40 trials
81.8%
-4.7% vs benchmark
3%
1 trials in Phase 3/4
17%
3 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (40)
Screening Protocol for Genetic Diseases of Allergic Inflammation
Immunoglobulin G Therapy Dose Optimization
Assessment of the Increased Risk of Infection Following an Ultratrail
Allergy and Immunology Natural History Study
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
X-linked Moesin Associated Immunodeficiency
Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults
Immune Homeostasis in Sepsis and Septic Shock
Nutrition, Immunity, and Covid-19 in Obese People
Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency
Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
Approaches and Metrics in Fraily Patients During COVID-19 Era
Immunoparalysis in Acute Kidney Injury After Cardiac Surgery
Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy
T-cell Depleted Alternative Donor Transplantation
Mechanisms of Immune Deficiency